Literature DB >> 25062739

Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation.

Silvia Ottaviani1, Alexander de Giorgio1, Victoria Harding1, Justin Stebbing1, Leandro Castellano2.   

Abstract

Despite its identification over 100 years ago, new discoveries continue to add to the complexity of the regulation of the endocrine system. Today the nuclear receptors (NRs) that play such a pivotal role in the extensive communication networks of hormones and gene expression remain an area of intense research. By orchestrating core processes, from metabolism to organismal development, the gene expression programs they control are dependent on their cellular context, their own levels, and those of numerous co-regulatory proteins. A previously unknown component of these networks, noncoding RNAs (ncRNAs) are now recognized as potent regulators of NR signaling, influencing receptor and co-factor levels and functions while being reciprocally regulated by the NRs themselves. This review explores the regulation enacted by microRNAs and long ncRNAs on NR function, using representative examples to show the varied roles of ncRNAs, in turn producing significant effects on the NR functional network in health and disease.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  eRNA; lncRNA; miRNA; microRNA; noncoding RNA; nuclear receptors

Mesh:

Substances:

Year:  2014        PMID: 25062739     DOI: 10.1530/JME-14-0134

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  7 in total

Review 1.  MicroRNAs and the regulation of aldosterone signaling in the kidney.

Authors:  Michael B Butterworth
Journal:  Am J Physiol Cell Physiol       Date:  2015-02-11       Impact factor: 4.249

Review 2.  Non-coding RNA crosstalk with nuclear receptors in liver disease.

Authors:  Jianguo Wu; Laura E Nagy; Suthat Liangpunsakul; Li Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-24       Impact factor: 5.187

Review 3.  Non-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genome.

Authors:  Kazuo Murakami
Journal:  Curr Hypertens Rev       Date:  2015

4.  Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway.

Authors:  Huixia Lu; Xunian Zhou; Hoi-Hin Kwok; Mei Dong; Zhaoqiang Liu; Po-Ying Poon; Xiaorong Luan; Ricky Ngok-Shun Wong
Journal:  Front Pharmacol       Date:  2017-11-13       Impact factor: 5.810

5.  SNHG6 203 RNA May be Involved in the Cell Cycle Progression in HER2-Negative Breast Cancer Cells.

Authors:  Amin Jafari-Oliayi; Shahriar Dabiri
Journal:  Iran J Pathol       Date:  2022-08-11

6.  Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity.

Authors:  Anais Mounier; Danko Georgiev; Kyong Nyon Nam; Nicholas F Fitz; Emilie L Castranio; Cody M Wolfe; Andrea A Cronican; Jonathan Schug; Iliya Lefterov; Radosveta Koldamova
Journal:  J Neurosci       Date:  2015-08-26       Impact factor: 6.167

7.  Non-genomic effects of the Pregnane X Receptor negatively regulate platelet functions, thrombosis and haemostasis.

Authors:  Gagan D Flora; Khaled A Sahli; Parvathy Sasikumar; Lisa-Marie Holbrook; Alexander R Stainer; Sarah K AlOuda; Marilena Crescente; Tanya Sage; Amanda J Unsworth; Jonathan M Gibbins
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.